Has Raymond Turner, MD received payments from drug or device companies?

Yes. Drug and device makers reported $152,225 in general payments to Raymond Turner, MD across 175 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Raymond Turner, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Raymond Turner, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Raymond Turner, MD

Neurology · Washington, DCNPI 1801977939

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $102,075 of the $152,225 with a category attached, or 67.1%. Lilly USA, LLC accounts for 68.3% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $67,139, more than ten times the $4,213 reported in 2019.

$152,225in general payments, 2019–2025

Across 175 payments — averaging $869.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lilly USA, LLC$104K
Eisai Inc.$30K
Eli Lilly$7K
Biogen$5K
Sage Therapeutics, LLC$3K
Genentech, Inc.$2K
plus $566 from 5 others

$16,747,525in research payments, 2019–2025

Across 370 payments — averaging $45,264 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$8.7M
Eisai Inc.$2.3M
Biogen$1.9M
Genentech, Inc.$1.6M
Novartis$880K
GSK$620K
plus $731K from 8 others

What the payments were for

Consulting fees$41,56427%
Speaking & faculty fees$102,07567%
Travel & lodging$5,0183%
Food & beverage$3,3782%
Education$1890%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lilly USA, LLC	109	$103,899
Eisai Inc.	31	$30,424
Eli Lilly	8	$7,327
Biogen	17	$5,029
Sage Therapeutics, LLC	1	$3,000
Genentech, Inc.	2	$1,980
F. Hoffmann-la Roche AG	2	$160
Life Molecular Imaging Ltd	2	$157
Baxter Healthcare	1	$131
Genentech USA, Inc.	1	$92
Novartis	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

KISUNLA$99,820
Leqembi$12,980
NEURACEQ$151
TISSEEL$131

How this compares

$152,225 in reported general payments places this provider in the 85th percentile of 113 neurology providers in District of Columbia.

See all neurology providers in District of Columbia →

Medicare billing

Part B allowed, 2024

$10,578

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Washington

Laxman BahrooWashington$3.1M
Fahd AmjadWashington$2M
Jessica AilaniWashington$1.2M
Yasar Torres-YaghiWashington$969K
Benjamin OsborneWashington$747K
Fernando PaganWashington$690K
Faria AmjadWashington$557K
Brian BarryWashington$359K
Carrie DoughertyWashington$327K
Carlo TornatoreWashington$318K

See the full list for District of Columbia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →